JSA advised and represented Temasek in its follow-on investment in Dr Agarwal’s Health Care Limited (Dr Agarwal’s) along with global private equity fund TPG Growth Capital (“TPG”). This round also saw the exit of ADV Partners through a buy-out by TPG.
Dr Agarwal’s is the largest eye care chain in India and Africa, and a preferred hospital and diagnostic chain for the eye care needs of millions across the globe, operating over 100 centres across 11 countries and 12 Indian states.
JSA Deal team comprised Lead Partner – Vikram Raghani, Partner – Rishabh Gupta, Partner – Sahil Shah, and Associate – Jinay Shah and Akshath Mithal.
JSA Competition team comprised – Partner & Head of Practice – Competition Law – Vaibhav Choukse, Principal Associate – Ela Bali, and Senior Associate – Aditi Khanna.
Ela is a partner with JSA’s competition law practice with 10 years of experience. She represents and advises clients across different sectors on enforcement and merger control matters before the Competition Commission of India (CCI), National Company Law Appellate Tribunal (NCLAT), Delhi and Bombay High Court, and the Supreme Court of India (SC).
Rishabh specializes in corporate transaction advisory, including private equity fund-raises, and mergers and acquisitions. He has extensive experience with cross-border investments and sales, business transfers, and leveraged and structured acquisitions, at every stage of the growth cycle.
Vaibhav is a Partner with Firm’s Competition Law Practice with over 15 years’ experience.
Vikram is a Partner with the Corporate Practice at JSA. His areas of practice include mergers & acquisitions, private equity and securities laws (including capital markets). He has been involved in private equity and mergers & acquisitions transactions also focusing on public market investments and M&A.